BSD Medical chairman Paul Turner reports 9.8% stake in BSD Medical

By E. Janene Geiss

Philadelphia, Oct. 15 - Paul F. Turner reported a 9.8% stake in BSD Medical Corp. Ltd. as of Aug. 31, according to an SC 13G filing with the Securities and Exchange Commission.

The passive stake represents 2,094,994 common shares, which includes 277,212 stock options to purchase common stock that were exercisable Aug. 31 or within 60 days of Aug. 31, and 1,710,158 shares held by Family Focus TH Ltd. Paul Turner, the company's chairman and chief technology officer, and Judith Turner share voting power and investment power over Family Focus.

BSD is a medical systems development company located in Salt Lake City.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.